Skip to main content
Joseph Pagano, MD, Infectious Disease, Chapel Hill, NC

JosephSPaganoMDProf.

Infectious Disease • Chapel Hill, NC

Healthcare Associated Infections, Transplant/Immunocompromised States

Physician

Join to view full profile

Dr. Pagano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pagano's full profile

Already have an account?

  • Office

    101 Manning Dr
    Chapel Hill, NC 27514
    Phone+1 919-966-4996
    Fax+1 919-843-5515

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1960 - 1961
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1957 - 1958
  • Yale School of Medicine
    Yale School of MedicineClass of 1957

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1965 - 2020

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 1998

Publications & Presentations

PubMed

Journal Articles

  • Expression of Interferon Regulatory Factor 7 Correlates with the Expression of Epstein–Barr Virus Latent Membrane Protein 1 and Cervical Lymph Node Metastasis in Nasop...  
    Joseph Pagano, MD, Pathology International

Grant Support

  • Cellular And Viral Regulation Of EBV Latency: Implication Of Ubiquitin-Editing ENNational Cancer Institute2011
  • Basic Mechanisms Of Viral And Chemical CarcinogenesisNational Cancer Institute1985–2011
  • New EBV Therapies For Treating MalignanciesNational Heart, Lung, And Blood Institute2005–2009
  • Cellular And Viral Regulation Of Type III EBV LatencyNational Cancer Institute2005–2009
  • Interferon Regulatory Factor 7 EBV Latency &OncogenesisNational Institute Of Allergy And Infectious Diseases2003
  • EBV Vectors For Targeted Gene Therapy Of B-LymphomasNational Heart, Lung, And Blood Institute2000–2003
  • Cellular Regulation Of Type III EBV LatencyNational Cancer Institute1999–2002
  • Interferon Regulatory Factors Cell Cycle And EBV LatencyNational Institute Of Allergy And Infectious Diseases1998–2002
  • Major Programs For Cancer Center SupportNational Cancer Institute1997–2002
  • Core--Developmental ProjectsNational Cancer Institute1997–2002
  • RAZ, A Transdominant Repressor, Modulates EBV ReactivationNational Cancer Institute1994–1999
  • Herpesviral Oncogenesis, Latency And ReactivationNational Cancer Institute1994–1999
  • Lineberger Cancer Control Education ProgramNational Cancer Institute1992–1996
  • Cancer Center Support GrantNational Cancer Institute1985–1996
  • CancerNational Cancer Institute1994
  • Expression And Regulation Of EBV DNA PolymeraseNational Cancer Institute1992–1994
  • Viral Oncogenesis And LatencyNational Cancer Institute1989–1994
  • Expansion Of The Lineberger Comprehensive Cancer CenterNational Cancer Institute1992–1993
  • Oncogenic Potential Of EBV Latency And Transforming GeneNational Cancer Institute1992
  • Fifth International Symposium On EBV And Associated DISNational Cancer Institute1992
  • Antiviral Drugs And Epstein-Barr Virus Infection StatesNational Institute Of Allergy And Infectious Diseases1991–1992
  • HTLV-III, Antiviral Drugs &Ebv In B CellsNational Institute Of Allergy And Infectious Diseases1986–1988
  • DNA Virus Genomes, Oncogenesis And LatencyNational Cancer Institute1985–1988
  • Acyclovir And Other Drug Inhibition Of EBV ReplicationNational Institute Of Allergy And Infectious Diseases1985–1987

Dr. Joseph Pagano, Dr. Joseph Pagano, MD, Dr. J Pagano, Dr. Joseph S Pagano